Spot Alert

Poll

Dog Named Spot?-or Baby It's Cold Outside?

After 6 weeks of coping with itchy lesions on her arms and legs, a 43-year-old woman seeks medical advice. The rash first erupted with the onset of cold weather. The patient recently acquired a dog.

Your differential diagnosis includes which of the following?

Psoriasis
Dermatophyte infection
Nummular eczema
Contact dermatitis
Pityriasis rosea
Recent Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Interview with Kelly Moore, MD, MPH, president, chief executive officer, Immunization Action Coalition
Related Content
Reconstituted ACIP Votes Yes on Clesrovimab for Infants and Flu Shot For All, But Thimerosal Has Got to Go

Reconstituted ACIP Votes Yes on Clesrovimab for Infants and Flu Shot For All, But Thimerosal Has Got to Go

Richard Payerchin
June 27th 2025
Article

The new, 7-member committee was clear on its support for the mAb for infants and the essential role of vaccination against influenza but wants an alternative preservative to thimerosal.

Weekly Dose: A Roundup of Top Stories for Primary Care Physicians

Weekly Dose: A Roundup of Top Stories for Primary Care Physicians

Sydney Jennings
May 7th 2025
Podcast

PODCAST: Listen to our first episode for new research on bacterial vaginosis, a new treatment option for chronic urticaria, and more.

Lenacapavir Approved for Twice-Yearly Injection for HIV Prevention, a Landmark FDA Decision / image credit ©Waldenmarus/stock.adobe.com

Lenacapavir Approved for Twice-Yearly Injection for HIV Prevention, a Landmark FDA Decision

Killian Meara
June 19th 2025
Article

The only pre-exposure prophylaxis approved for twice-a-year dosing, lenacapavir "could be the transformative PrEP option we’ve been waiting for," one expert said.

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Keith A. Reynolds
October 1st 2024
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Steven P. Furr, former president of the American Academy of Family Physicians.

FDA Advisory Panel Recommends Continued Use of Monovalent JN.1 Strain for COVID-19 Vaccines / Image credit: ©Tada Images/AdobeStock

FDA Advisory Panel Recommends Continued Use of Monovalent JN.1 Strain for COVID-19 Vaccines

Sydney Jennings
May 27th 2025
Article

FDA panel endorses continued use of monovalent JN.1 strain for COVID-19 vaccines, aligning with global health recommendations amid evolving variants.

FDA grants Novavax COVID-19 vaccine full approval for high risk groups / image credit ©Waldenmarus/stock.adobe.com

FDA Grants Novavax COVID-19 Vaccine Full Approval for High-Risk Groups

Grace Halsey
May 20th 2025
Article

Nuvaxovid (NVX-CoV2373) is indicated for those aged ≥65 years and aged 12 to 64 years with at least one condition that puts them at high risk for severe infection.

© 2025 MJH Life Sciences

All rights reserved.